Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.

作者: Eriko Nitta , Koji Izutsu , Yuko Yamaguchi , Yoichi Imai , Seishi Ogawa

DOI: 10.1038/SJ.ONC.1208754

关键词:

摘要: Evi-1 is a transcription factor that implicated in leukemic transformation of hematopoietic cells. Two distinct alternative forms, Evi-1a and Evi-1c, are generated from the EVI-1 gene. Whereas widely recognized as an oncoprotein, role for which has additional PR domain amino-terminus Evi-1a, leukemogenesis, not been elucidated thus far. Aberrant oligomerization factors recently emerged prevalent mechanism activating their oncogenic potential malignancies. Here, to study mechanisms underlie Evi-1-mediated oncogenesis, we investigated formation oligomeric complexes by proteins. We show forms homo-oligomers, whereas Evi-1c exclusively exists monomer mammalian Remarkably, lost ability interact with CtBP, transcriptional corepressor associates Evi-1a. As consequence, repress transforming growth factor-β (TGF-β) signaling significantly abrogated. These results identify novel function regulate suggest homo-oligomerization may play critical recruitment In addition, found chimeric oncoprotein acute myelocytic leukemia (AML)1-Evi-1, t(3;21) leukemia, also homo-oligomers hetero-oligomers while it did Evi-1c. Consistent results, repression TGF-β AML1-Evi-1 was enhanced hardly affected presence contribute Evi-1-containing

参考文章(20)
Mineo Kurokawa, Kinuko Mitani, Kenji Irie, Tomohiro Matsuyama, Tokiharu Takahashi, Shigeru Chiba, Yoshio Yazaki, Kunihiro Matsumoto, Hisamaru Hirai, The oncoprotein Evi-1 represses TGF-Beta signalling by inhibiting Smad3 Nature. ,vol. 394, pp. 92- 96 ,(1998) , 10.1038/27945
Chi Wai So, Michael L. Cleary, Dimerization: a versatile switch for oncogenesis Blood. ,vol. 104, pp. 919- 922 ,(2004) , 10.1182/BLOOD-2004-03-0992
Chi Wai So, Min Lin, Paul M Ayton, Everett H Chen, Michael L Cleary, Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias Cancer Cell. ,vol. 4, pp. 99- 110 ,(2003) , 10.1016/S1535-6108(03)00188-0
Koji Izutsu, Mineo Kurokawa, Yoichi Imai, Kazuhiro Maki, Kinuko Mitani, Hisamaru Hirai, The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling Blood. ,vol. 97, pp. 2815- 2822 ,(2001) , 10.1182/BLOOD.V97.9.2815
Mary Ellen Martin, Thomas A Milne, Sebastien Bloyer, Karine Galoian, Weiping Shen, Denise Gibbs, Hugh W Brock, Robert Slany, Jay L Hess, Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. ,vol. 4, pp. 197- 207 ,(2003) , 10.1016/S1535-6108(03)00214-9
Giorgio Lagna, Akiko Hata, Ali Hemmati-Brivanlou, Joan Massagué, Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. ,vol. 383, pp. 832- 836 ,(1996) , 10.1038/383832A0
Yoichi Imai, Mineo Kurokawa, Koji Izutsu, Akira Hangaishi, Kazuhiro Maki, Seishi Ogawa, Shigeru Chiba, Kinuko Mitani, Hisamaru Hirai, Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Oncogene. ,vol. 20, pp. 88- 96 ,(2001) , 10.1038/SJ.ONC.1204057
Chris Bartholomew, Susan Palmer, Jean-Paul Brouillet, Anna Kilbey, Ruth Fulton, Mark Walker, Merlin Crossley, Evi-1 Transforming and Repressor Activities Are Mediated by CtBP Co-repressor Proteins Journal of Biological Chemistry. ,vol. 276, pp. 25834- 25840 ,(2001) , 10.1074/JBC.M102343200